During the past decade, Cornell Clinical Trials Unit - Chelsea Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cornell Clinical Trials Unit - Chelsea Clinic" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials, followed by "AIDS Malignancy Consortium" with 3 trials sponsored, "Abbott" with 3 trials sponsored, "AIDS Clinical Trials Group" with 1 trials sponsored and "Aronex Pharmaceuticals" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cornell Clinical Trials Unit - Chelsea Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "The Emmes Company, LLC" with 3 trials as a collaborator, "University of Arkansas" with 3 trials as a collaborator, "AIDS and Cancer Specimen Resource" with 1 trials as a collaborator and "Inovio Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Cornell Clinical Trials Unit - Chelsea Clinic" are "HIV Infections" (15 trials), "HIV Infection" (2 trials), "Anal Cancer" (1 trials), "Anal Intraepithelial Neoplasia" (1 trials) and "Cytomegalovirus Retinitis" (1 trials). Many other conditions were trialed in "Cornell Clinical Trials Unit - Chelsea Clinic" in a lesser frequency.

Most popular intervention types in "Cornell Clinical Trials Unit - Chelsea Clinic" are "Drug" (13 trials), "Biological" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (3 trials), "Lopinavir/Ritonavir" (3 trials), "Stavudine" (3 trials), "Indinavir sulfate" (2 trials) and "Nevirapine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cornell Clinical Trials Unit - Chelsea Clinic" are 19 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cornell Clinical Trials Unit - Chelsea Clinic". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Cornell Clinical Trials Unit - Chelsea Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cornell Clinical Trials Unit - Chelsea Clinic, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".